| P50 | author | David Kupfer | Q5236159 |
| | Martica Hall | Q88067326 |
| P2093 | author name string | Ellen Frank | |
| | Brant Hasler | |
| | Carol A Janney | |
| | Isabella Soreca | |
| | Meredith L Wallace | |
| | Fiona C Ritchey | |
| | Jessica C Levenson | |
| | Joan Buttenfield | |
| | Matthew C Fleming | |
| P2860 | cites work | Psychosocial Disability in the Course of Bipolar I and II Disorders | Q22253033 |
| | A rating scale for depression | Q24564540 |
| | Stress and the individual. Mechanisms leading to disease | Q28262768 |
| | Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 |
| | Metabolic consequences of sleep and circadian disorders | Q28386791 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | Are sleep and depression independent or overlapping risk factors for cardiometabolic disease? | Q34084729 |
| | Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders? | Q34105869 |
| | Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). | Q35146063 |
| | Clinical and health services relationships between major depression, depressive symptoms, and general medical illness | Q35189628 |
| | Associations between sleep loss and increased risk of obesity and diabetes | Q35388325 |
| | The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? | Q35841353 |
| | Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers | Q35901587 |
| | Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials | Q36165238 |
| | Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program | Q36630487 |
| | Sleep duration is associated with dyslipidemia in patients with bipolar disorder in clinical remission | Q36728737 |
| | Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder | Q37031036 |
| | Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder | Q37218782 |
| | Premature mortality from general medical illnesses among persons with bipolar disorder: a review | Q37379526 |
| | Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder | Q37426682 |
| | Cardiovascular disease and bipolar disorder: risk and clinical implications | Q38071732 |
| | Prevalence, chronicity, burden and borders of bipolar disorder | Q38088053 |
| | Self-management and bipolar disorder--a clinician's guide to the literature 2011-2014. | Q38239842 |
| | Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q43244286 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | Applying clinical staging to young people who present for mental health care | Q44828227 |
| | A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 |
| | Comorbidities and mortality in bipolar disorder: a Swedish national cohort study | Q46091232 |
| | The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Chronotype and body composition in bipolar disorder | Q48400738 |
| | A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials | Q48424181 |
| | Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach | Q48542991 |
| | An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009 | Q50128169 |
| | Analysis of affective instability in ecological momentary assessment: Indices using successive difference and group comparison via multilevel modeling. | Q50765353 |
| | Integrating medical and psychiatric care in patients with bipolar disorder. | Q51892747 |
| | Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. | Q51914417 |
| | Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 |
| | Should bipolar disorder be considered a systemic illness? | Q57612509 |
| | Does Treatment Influence Mortality in Depressives?: A Follow-up of 1076 Patients with Major Affective Disorders | Q57697308 |
| | Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders | Q57697316 |
| | Predictors of immediate response in the treatment of mania: The importance of comorbidity | Q57697317 |
| | Clinical correlates of current level of functioning in primary care-treated bipolar patients | Q57849268 |
| | The increasing medical burden in bipolar disorder | Q81782161 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar I disorder | Q4915474 |
| P304 | page(s) | 424-437 | |
| P577 | publication date | 2014-12-12 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial | |
| P478 | volume | 17 | |